Agrinos raises $14.7M in equity investment to further grow its biological crop nutrition business.

Agrinos, an Oslo, Norway-based company developing biological crop nutrition products, announced securing $14.7M in investment in the company.

The money comes from strategic investors including Manor Investment SA, Havfonn AS and EuroChem Group AG, and is structured as a $5.3M conversion of debt, with the remaining $9.4M settled by cash contribution.

In addition to approving the equity investment, Agrinos’ Board of Directors welcomed Frederic de Stexhe, a Principal at Manor, as a new board member.

Agrinos, founded in 2009 and led by CEO Kevin Helash, is a biological crop input provider committed to improving the productivity and sustainability of modern agriculture. Agrinos’ range of biofertilizers and biostimulant products helps farmers to practice profitable agriculture by providing increased crop productivity, improved efficiency of conventional fertilizer and a reduced environmental footprint.